ArticleOncoimmunology2015

Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

Colin de Haar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.